Mineralys Therapeutics, Inc.
MLYSNext catalyst
Lorundrostat
Hypertension, in combination with other antihypertensive drugs
Get an email about MLYS's next catalysts
Track Mineralys Therapeutics (MLYS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (regulatory event).See the timeline
2 upcoming, 1 past
Regulatory
A Mineralys insider realized a $557,000 options gain ahead of a December FDA decision date. The article reports insider trading activity without providing details on the drug, indication, or regulatory decision type.
SourceFDA PDUFA Date lorundrostat
For Hypertension, in combination with other antihypertensive drugs. NDA. Verified against the company announcement on 2026-10-16.
SourceUpcoming FDA decisions
Market Overview
Stock performance and key metrics
lorundrostat Dose 1
Hypertension
Lorundrostat
Obstructive Sleep Apnea
lorundrostat Dose 2
Hypertension
MLS-101 (Part I)
Hypertension, Renal
MLS-101 (Part II)
Hypertension, Renal
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
lorundrostat Dose 1 | Phase 3 | Hypertension | - | - |
Lorundrostat | Phase 3 | Obstructive Sleep Apnea | - | - |
lorundrostat Dose 2 | Phase 3 | Hypertension | - | - |
MLS-101 (Part I) | Phase 2 | Hypertension, Renal | - | - |
MLS-101 (Part II) | Phase 2 | Hypertension, Renal | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Mineralys Therapeutics, Inc.'s drug pipeline?β
CatalystAlert tracks 5 drug candidates in Mineralys Therapeutics, Inc.'s (MLYS) pipeline across Phase 3, Phase 2. Its lead program is Lorundrostat (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Mineralys Therapeutics, Inc.'s next FDA catalyst?β
Mineralys Therapeutics, Inc.'s (MLYS) next tracked catalyst is a PDUFA date expected Dec 22, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track MLYS biotech catalysts?β
Add MLYS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Mineralys Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
